Stuart A. Arbuckle - Insider Trading & Ownership

Location
Vertex Pharmaceuticals Incorporated, 130 Waverly St., Cambridge, MA
Summary
The estimated net worth of Stuart A. Arbuckle is at least $29.1M dollars as of July 2, 2025. Stuart A. Arbuckle is the EVP, COO of VERTEX PHARMACEUTICALS INC / MA and owns shares of VERTEX PHARMACEUTICALS INC / MA (VRTX) stock worth about $28.6M. Stuart A. Arbuckle is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $413K. Stuart A. Arbuckle is the Director of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $102K.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Stuart A. Arbuckle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRTX VERTEX PHARMACEUTICALS INC / MA Evp, Coo $28.6M Jul 1, 2025
RYTM RHYTHM PHARMACEUTICALS, INC. Director $413K Jun 24, 2025
IMGN ImmunoGen, Inc. Director $102K Feb 12, 2024

Insider Transactions Reported by Stuart A. Arbuckle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.